SMTL ID : 1uvq.1

Crystal structure of HLA-DQ0602 in complex with a hypocretin peptide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)

NAG-NAG-BMA-FUC.1: 4 residues within 4Å: Chain B: N.17, T.19, E.20, R.21 No protein-ligand interaction detected (PLIP)

1 x GLY: GLYCINE(Non-covalent)

GLY.2: 3 residues within 4Å: Chain A: D.113, K.143, F.149 3 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:K.143, A:K.143 Water bridges: B:R.147

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 3 residues within 4Å: Chain A: N.121, E.169, W.171 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.121 NAG.4: 3 residues within 4Å: Chain A: R.79, N.81 Chain B: Q.51 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:Q.51

1 x ZN: ZINC ION(Non-covalent)

ZN.5: 2 residues within 4Å: Chain B: D.74, H.79 2 PLIP interactions: 2 interactions with chain B Metal complexes: B:D.74, B:H.79

1 x ACY: ACETIC ACID(Non-functional Binders)

ACY.6: 5 residues within 4Å: Chain A: Y.80, T.83 Chain B: Y.30, N.31, E.33 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:N.31 Water bridges: B:R.32, B:R.32 Hydrophobic interactions: A:Y.80, A:T.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Siebold, C. et al., Crystal Structure of Hla-Dq0602 that Protects Against Type 1 Diabetes and Confers Strong Susceptibility to Narcolepsy. Proc.Natl.Acad.Sci.USA (2004)

Release Date

2004-02-05

Peptides

HLA CLASS II HISTOCOMPATIBILITY ANTIGEN: A
HLA CLASS II HISTOCOMPATIBILITY ANTIGEN: B
OREXIN: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

HLA CLASS II HISTOCOMPATIBILITY ANTIGEN

HLA CLASS II HISTOCOMPATIBILITY ANTIGEN

OREXIN